120
Participants
Start Date
March 1, 2016
Primary Completion Date
June 20, 2026
Study Completion Date
June 20, 2026
Anti-Parkinson medication
During the optional second visit subjects with neurological disease and already on anti-parkinson medication are asked to come off their anti-parkinson medication.
Deep Brain Stimulation
During the optional second visit subjects with neurological disease already treated with deep brain stimulation are asked to come temporarily stop deep brain stimulation and resume stimulation, with walking trials done in each condition.
RECRUITING
Clinical Research Center BIDMC, Boston
Beth Israel Deaconess Medical Center
OTHER